Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sarkar

Showing results (181-190 of 669) with videos related to

Pageof 67
Sort By:
Cancer Research|March 1, 1975
The morphology of murine oncornaviruses following different methods of preparation for electron microscopyN H Sarkar, W J Manthey, J B Sheffield
Pancreas|December 11, 2014
The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and EpigenomeYiwei Li, Vay Liang W Go, Fazlul H Sarkar
Pancreatic Disorders & Therapy|November 13, 2012
The Role of EMT in Pancreatic Cancer ProgressionQiong Wu, Lucio Miele, Fazlul H Sarkar, et al.
Plos One|March 17, 2011
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancerBin Bao, Shadan Ali, Dejuan Kong, et al.
Stem Cells (Dayton, Ohio)|April 12, 2008
Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cellsDejuan Kong, Zhiwei Wang, Sarah H Sarkar, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|July 1, 1998
Molecular analysis of the p53 gene in pancreatic adenocarcinomaY Li, M Bhuiyan, V K Vaitkevicius, et al.
Journal of Cancer Science & Therapy|January 26, 2016
Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous CystadenomaRichard Licheng Wu, Shadan Ali, Fazlul H Sarkar, et al.
Cancer Research|January 1, 1973
Some physical and biological characteristics of the mouse mammary tumor virusD H Moore, N H Sarkar, J Charney, et al.
Pancreas|January 15, 1999
Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinomaY Li, M Bhuiyan, V K Vaitkevicius, et al.
Pharmaceutical Research|April 8, 2010
Critical need for clinical trials: an example of a pilot human intervention trial of a mixture of natural agents protecting lymphocytes against TNF-alpha induced activation of NF-kappaBKristin Dominiak, Jaclyn McKinney, Lance K Heilbrun, et al.
Pageof 67

Showing results (181-190 of 669) with videos related to

Sort By:
Pageof 67
Cancer Research|March 1, 1975
The morphology of murine oncornaviruses following different methods of preparation for electron microscopyN H Sarkar, W J Manthey, J B Sheffield
Pancreas|December 11, 2014
The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and EpigenomeYiwei Li, Vay Liang W Go, Fazlul H Sarkar
Pancreatic Disorders & Therapy|November 13, 2012
The Role of EMT in Pancreatic Cancer ProgressionQiong Wu, Lucio Miele, Fazlul H Sarkar, et al.
Plos One|March 17, 2011
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancerBin Bao, Shadan Ali, Dejuan Kong, et al.
Stem Cells (Dayton, Ohio)|April 12, 2008
Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cellsDejuan Kong, Zhiwei Wang, Sarah H Sarkar, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|July 1, 1998
Molecular analysis of the p53 gene in pancreatic adenocarcinomaY Li, M Bhuiyan, V K Vaitkevicius, et al.
Journal of Cancer Science & Therapy|January 26, 2016
Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous CystadenomaRichard Licheng Wu, Shadan Ali, Fazlul H Sarkar, et al.
Cancer Research|January 1, 1973
Some physical and biological characteristics of the mouse mammary tumor virusD H Moore, N H Sarkar, J Charney, et al.
Pancreas|January 15, 1999
Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinomaY Li, M Bhuiyan, V K Vaitkevicius, et al.
Pharmaceutical Research|April 8, 2010
Critical need for clinical trials: an example of a pilot human intervention trial of a mixture of natural agents protecting lymphocytes against TNF-alpha induced activation of NF-kappaBKristin Dominiak, Jaclyn McKinney, Lance K Heilbrun, et al.
Pageof 67